[248 Pages Report] As per Future Market Insight’s latest published report, the global Next Generation Optical Biometry Devices Market was valued at US$ 320.7 Million in 2021.
| Attribute | Details |
|---|---|
| Next Generation Optical Biometry Devices Market Size (2021) | US$ 320.7 Million |
| Sales Forecast for Next Generation Optical Biometry Devices (2028) | US$ 461.3 Million |
| Global Market Growth (2022 to 2028) | 5.4% CAGR |
| Market Share of Top 5 Next Generation Optical Biometry Device Manufacturers | 60% |
Sales of next generation optical biometry devices are slated to rise at a CAGR of 5.4% to reach US$ 461.3 Million by 2028.
In 2021, next generation optical biometry device shipments represented 16.1% share of the global ophthalmic imaging devices market. Hospitals account for 41.8% revenue share of the next generation optical biometry devices
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 5.11% |
| H1, 2022 Projected | 5.36% |
| H1, 2022 Outlook | 4.76% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 60 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (-) 35 ↓ |
According to Future Market Insights analysis, the global next generation optical biometry devices market expects to drop by 35 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 projected value, the market during H1-2022 outlook period will show a dip of 60 BPS.
Major factors attributed to this dip includes lack of trained professionals, and a high cost of optical biometry devices which is set to provide a restrictive impact upon the market growth through the forecasted years.
Moreover, advances in product design and integration of digitalized solutions together with product adoption scenario may be impacted with the cost constraints of initial equipment setting up, as well as the gradual maintenance and upgrade costs to follow.
Following several restrictive scenarios, the market has observed a change in the BPS values, and thus will be likely to experience a slow progression towards sales adoption over the next few years.
However, increasing incidence of eye diseases such as cataract and refractive errors coupled with rising number of eye care clinics and hospitals across the world are factors driving adoption of next generation optical biometry devices.
With advancements in technology, automated versions of next generation optical biometry devices have been developed aiding measurement of eyes before refractive and cataract surgeries. Such factors are expected to influence the market growth in upcoming years.
As per FMI, the global next generation optical biometry devices market was valued at US$ 320.7 Mn in 2021.
Increasing incidence of eye diseases such as cataract and refractive errors coupled with rising number of eye care clinics and hospitals across the world are factors driving adoption of next generation optical biometry devices.
With advancements in technology, next generation optical biometry devices have been developed aiding measurement of eyes before refractive and cataract surgeries.
Next generation optical biometry devices are automated and measure various parameters such as axial length, anterior chamber depth, thickness of lens, retinal thickness, pupil size, and much more.
Next generation optical biometry devices are an accurate alternative for precise measurements and provide efficient results. Also, next generation optical biometry equipment avoid operator variations in measurements.
Rapid increase in the number of probe infections due to usage of ultrasound devices lead to post-operative errors, fueling demand for next generation optical biometry devices instead of ultrasound devices.
Manufacturers of next generation optical biometry devices are introducing automated instruments that are more efficient in measuring the segments of the eyes. Next generation optical biometry device suppliers are working on strengthening the related software to provide detailed information about the eye segments.
Companies manufacturing optical biometry devices are collaborating with local distributors/retailers to increase the product penetration of next generation optical biometry equipment.
Considering this, it is expected that the global next generation optical biometry devices market will rise at a CAGR of 5.4% over the forecast period.
Principal Consultant
The North American next generation optical biometry devices market is projected to account for 26.8% of the global market share in 2022.
According to the Prevent Blindness organization, 25 Mn Americans having cataract require medical care every year in the U.S., thereby boosting demand for next generation optical biometry equipment in the region.
Rising acceptance of advanced optical biometry equipment, quick development of eye care infrastructure, and changing lifestyles are some of the factors that are predicted to contribute to next generation optical biometry devices market expansion in the region.
The USA government has increased its healthcare expenditure to approximately 7% by providing Medicare and Medicaid services - fueling availability of reimbUSAment for cataract surgeries. This is driving demand for advanced next generation optical biometry devices.
Patient safety is of topmost priority in the USA, which signals demand for faster and better ocular imaging. Emergence of optical devices, high potency and fastness of these devices, and growing number of hospitals are factors driving market growth of next generation optical biometry instruments and devices in the USA
Growing demand for next generation optical biometry devices is being noted in the UKdue to rising number of cataract surgeries.
Growing use of next generation optical biometry devices for cataract surgeries in hospitals as well as progressive increase in the number of government and private hospitals in the UKare expected to boost demand growth of next generation optical biometry devices.
Increase in the number of cataract treatments performed and rising adoption of innovative practices for such procedures will also propel the market forward.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In terms of revenue, swept-source optical coherent based biometry devices will account for significant revenue share in the next generation optical biometry devices industry over the forecast period. Swept-source optical coherent based biometry devices are set to exhibit highest revenue share in the next generation optical biometry devices market
Swept-source optical coherent based optical biometry devices are gaining popularity in the USA market. This category of next generation optical biometry devices is used especially at hospitals and ophthalmology clinics and specialized eye centers.
Some of the qualities driving demand for swept-source optical coherent based biometry devices include fast data capture, several measurements in a single process, enhanced wavelength, and the capacity to overcome ocular opacities.
The superiority of swept-source optical coherent based biometry devices over partial coherent interferometry is demonstrated by their ability to measure the axial length along six separate axes.
Hospitals account for 41.8% revenue share in next generation optical biometry device demand.
The market is predicted to grow as the number of private and government hospitals gradually increases. Growing use of next generation optical biometry devices in medical settings, such as hospitals, is expected to boost overall market expansion.
Medical services and vision benefits offered under Medicare include cataract surgeries, which will increase demand for next generation optical biometry devices over the coming years. Patients' increased trust in hospitals that are committed to providing all types of medical solutions will further fuel market growth.
COVID-19 posed significant challenges to the optical biometry devices market in recent months, pushing market participants to the limit. Companies are finding it harder to make informed judgments regarding their products, supply networks, and regulatory duties while the COVID-19 pandemic continues to unfold.
COVID-19 forced a lot of people to postpone medical treatment, which has the potential to have a significant influence on the healthcare industry. Manufacturers are figuring out how to recover from the current situation by reorganizing their sales channels and introducing new products. The global market for next generation optical biometry devices is likely to stabilize over the coming years.
The competition section of the next generation optical biometry devices industry report features the profiles of key players based on their market shares, differentiating strategies, product offerings, and marketing approach.
Key manufacturers of next generation optical biometry devices are focusing on novel marketing strategies to increase product penetration. Companies supplying next generation optical biometry products are concentrating on price floor strategies and offering lucrative discounts.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2028 |
| Historical Data Available for | 2013 to 2021 |
| Market Analysis | Value in US$ Million, Volume in Units |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia & Pacific; Middle East & Africa (MEA) |
| Key Countries Covered | USA, Canada, Mexico, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Nordic, Spain, Japan, China, India, Malaysia, Thailand, Australia, GCC Countries, South Africa, Turkey |
| Key Market Segments Covered | Product Type, End User, Region |
| Key Companies Profiled | Nidek Co Ltd.; Ziemer Ophthalmic Systems; TOMEY GmbH; Movu Inc.; OCULUS Optikgeräte GmbH.; Bausch & Lomb Incorporated; Topcon Corporation; Heine Optotechnik GmbH & Co. KG; AMETEK, Inc.; Optovue, Incorporated; Leica Microsystems GmbH |
| Pricing | Available upon Request |
The next generation optical biometry devices market is anticipated to experience a CAGR of 5.4%, culminating in a market valuation of US$ 461.3 million by 2028.
Challenges encompass high initial costs, data security concerns, privacy issues, and adapting to evolving reimbursement policies.
Fueled by the demand of 25 million people needing cataract care annually, North America leads the global next generation optical biometry devices market.
Swept-source optical coherence-based biometry devices secure significant revenue due to advanced imaging, better accuracy, and suitability for complex ocular conditions.
Rising eye disease prevalence, growing elderly population, accuracy-boosting tech advancements, and demand for minimally invasive surgeries drive product demand.
A recent key development in the market involves the introduction of portable handheld devices for telemedicine applications.
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Next Generation Optical Biometry Devices Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Global Economic Outlook
4.1. Global Gross Domestic Product by Region & Healthcare spending
5. Market Background
5.1. Value Chain Analysis
5.2. Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Trends
6. Macroeconomic Assumptions
7. Key Inclusions
7.1. Pricing Analysis
7.2. Value Chain Analysis
7.3. Regulatory Scenario
8. North America Next Generation Optical Biometry Devices Market Analysis 2013-2021 and Forecast 2022–2028
8.1. Introduction
8.2. Historical Market Value (US$ Mn) Analysis by Country, 2013-2021
8.2.1. U.S.
8.2.2. Canada
8.3. Market Value (US$ Mn) Forecast By Country, 2022–2028
8.4. Historical Market Value (US$ Mn) and Volume Analysis by Product Type, 2013-2021
8.4.1. Swept-source Optical Coherence Tomography (OCT) based Biometers
8.4.2. Partial coherence interferometry (PCI) based Biometers
8.4.3. Optical Low Coherence Reflectometry (OLCR) based Biometers
8.5. Market value (US$ Mn) and Volume Forecast by Product Type, 2022–2028
8.6. Historical Market Value (US$ Mn) Trend Analysis by End User, 2013-2021
8.6.1. Hospitals
8.6.2. Ophthalmology clinics and specialized eye care centers
8.6.3. Ambulatory Surgical centers
8.7. Market Value (US$ Mn) Forecast By End User 2022–2028
8.8. Market Attractiveness Analysis
8.8.1. By Country
8.8.2. By Product Type
8.8.3. By End User
8.9. Key Market Participants – Intensity Mapping
8.10. Drivers and Restraints: Impact Analysis
9. Western Europe Next Generation Optical Biometry Devices Market Analysis 2013-2021 and Forecast 2022–2028
9.1. Introduction
9.2. Historical Market Value (US$ Mn) Analysis by Country, 2013-2021
9.2.1. Germany
9.2.2. U.K
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Western Europe
9.3. Market Value (US$ Mn) Forecast By Country, 2022–2028
9.4. Historical Market Value (US$ Mn) and Volume Analysis by Product Type, 2013-2021
9.4.1. Swept-source Optical Coherence Tomography (OCT) based Biometers
9.4.2. Partial coherence interferometry (PCI) based Biometers
9.4.3. Optical Low Coherence Reflectometry (OLCR) based Biometers
9.5. Market value (US$ Mn) and Volume Forecast by Product Type, 2022–2028
9.6. Historical Market Value (US$ Mn) Trend Analysis by End User, 2013-2021
9.6.1. Hospitals
9.6.2. Ophthalmology clinics and specialized eye care centers
9.6.3. Ambulatory Surgical centers
9.7. Market Value (US$ Mn) Forecast By End User 2022–2028
9.8. Market Attractiveness Analysis
9.8.1. By Country
9.8.2. By Product Type
9.8.3. By End User
9.9. Key Market Participants – Intensity Mapping
9.10. Drivers and Restraints: Impact Analysis
10. Eastern Europe Next Generation Optical Biometry Devices Market Analysis 2013-2021 and Forecast 2022–2028
10.1. Introduction
10.2. Regional Market Trends
10.3. Historical Market Value (US$ Mn) Analysis by Country, 2013-2021
10.3.1. Russia
10.3.2. Poland
10.3.3. Rest of Eastern Europe
10.4. Market Value (US$ Mn) Forecast By Country, 2022–2028
10.5. Historical Market Value (US$ Mn) and Volume Analysis by Product Type, 2013-2021
10.5.1. Swept-source Optical Coherence Tomography (OCT) based Biometers
10.5.2. Partial coherence interferometry (PCI) based Biometers
10.5.3. Optical Low Coherence Reflectometry (OLCR) based Biometers
10.6. Market value (US$ Mn) and Volume Forecast by Product Type, 2022–2028
10.7. Historical Market Value (US$ Mn) Trend Analysis by End User, 2013-2021
10.7.1. Hospitals
10.7.2. Ophthalmology clinics and specialized eye care centers
10.7.3. Ambulatory Surgical centers
10.8. Market Value (US$ Mn) Forecast By End User 2022–2028
10.9. Market Attractiveness Analysis
10.9.1. By Country
10.9.2. By Product Type
10.9.3. By End User
10.10. Key Market Participants – Intensity Mapping
10.11. Drivers and Restraints: Impact Analysis
11. Latin America Next Generation Optical Biometry Devices Market Analysis 2013-2021 and Forecast 2022–2028
11.1. Introduction
11.2. Historical Market Value (US$ Mn) Analysis by Country, 2013-2021
11.2.1. Brazil
11.2.2. Mexico
11.2.3. Rest of Latin America
11.3. Market Value (US$ Mn) Forecast By Country, 2022–2028
11.4. Historical Market Value (US$ Mn) and Volume Analysis by Product Type, 2013-2021
11.4.1. Swept-source Optical Coherence Tomography (OCT) based Biometers
11.4.2. Partial coherence interferometry (PCI) based Biometers
11.4.3. Optical Low Coherence Reflectometry (OLCR) based Biometers
11.5. Market value (US$ Mn) and Volume Forecast by Product Type, 2022–2028
11.6. Historical Market Value (US$ Mn) Trend Analysis by End User, 2013-2021
11.6.1. Hospitals
11.6.2. Ophthalmology clinics and specialized eye care centers
11.6.3. Ambulatory Surgical centers
11.7. Market Value (US$ Mn) Forecast By End User 2022–2028
11.8. Market Attractiveness Analysis
11.8.1. By Country
11.8.2. By Product Type
11.8.3. By End User
11.9. Key Market Participants – Intensity Mapping
11.10. Drivers and Restraints: Impact Analysis
12. Asia Pacific Excluding China & Japan Next Generation Optical Biometry Devices Market Analysis 2013-2021 and Forecast 2022–2028
12.1. Introduction
12.2. Historical Market Value (US$ Mn) Analysis by Country, 2013-2021
12.2.1. India
12.2.2. Australia and New Zealand
12.2.3. ASEAN
12.2.4. Rest of APEJ
12.3. Market Value (US$ Mn) Forecast By Country, 2022–2028
12.4. Historical Market Value (US$ Mn) and Volume Analysis by Product Type, 2013-2021
12.4.1. Swept-source Optical Coherence Tomography (OCT) based Biometers
12.4.2. Partial coherence interferometry (PCI) based Biometers
12.4.3. Optical Low Coherence Reflectometry (OLCR) based Biometers
12.5. Market value (US$ Mn) and Volume Forecast by Product Type, 2022–2028
12.6. Historical Market Value (US$ Mn) Trend Analysis by End User, 2013-2021
12.6.1. Hospitals
12.6.2. Ophthalmology clinics and specialized eye care centers
12.6.3. Ambulatory Surgical centers
12.7. Market Value (US$ Mn) Forecast By End User 2022–2028
12.8. Market Attractiveness Analysis
12.8.1. By Country
12.8.2. By Product Type
12.8.3. By End User
12.9. Key Market Participants – Intensity Mapping
12.10. Drivers and Restraints: Impact Analysis
13. Japan Next Generation Optical Biometry Devices Market Analysis 2013-2021 and Forecast 2022–2028
13.1. Introduction
13.2. Historical Market Value (US$ Mn) and Volume Analysis by Product Type, 2013-2021
13.2.1. Swept-source Optical Coherence Tomography (OCT) based Biometers
13.2.2. Partial coherence interferometry (PCI) based Biometers
13.2.3. Optical Low Coherence Reflectometry (OLCR) based Biometers
13.3. Market value (US$ Mn) and Volume Forecast by Product Type, 2022–2028
13.4. Historical Market Value (US$ Mn) Trend Analysis by End User, 2013-2021
13.4.1. Hospitals
13.4.2. Ophthalmology clinics and specialized eye care centers
13.4.3. Ambulatory Surgical centers
13.5. Market Value (US$ Mn) Forecast By End User 2022–2028
13.6. Market Attractiveness Analysis
13.6.1. By Country
13.6.2. By Product Type
13.6.3. By End User
13.7. Key Market Participants – Intensity Mapping
13.8. Drivers and Restraints: Impact Analysis
14. Middle East and Africa Next Generation Optical Biometry Devices Market Analysis 2013-2021 and Forecast 2022–2028
14.1. Introduction
14.2. Historical Market Value (US$ Mn) Analysis by Country, 2013-2021
14.2.1. GCC Countries
14.2.2. South Africa
14.2.3. Rest of MEA
14.3. Market Value (US$ Mn) Forecast By Country, 2022–2028
14.4. Historical Market Value (US$ Mn) and Volume Analysis by Product Type, 2013-2021
14.4.1. Swept-source Optical Coherence Tomography (OCT) based Biometers
14.4.2. Partial coherence interferometry (PCI) based Biometers
14.4.3. Optical Low Coherence Reflectometry (OLCR) based Biometers
14.5. Market value (US$ Mn) and Volume Forecast by Product Type, 2022–2028
14.6. Historical Market Value (US$ Mn) Trend Analysis by End User, 2013-2021
14.6.1. Hospitals
14.6.2. Ophthalmology clinics and specialized eye care centers
14.6.3. Ambulatory Surgical centers
14.7. Market Value (US$ Mn) Forecast By End User 2022–2028
14.8. Market Attractiveness Analysis
14.8.1. By Country
14.8.2. By Product Type
14.8.3. By End User
14.9. Key Market Participants – Intensity Mapping
14.10. Drivers and Restraints: Impact Analysis
15. Forecast Factors: Relevance and Impact
16. Forecast Assumptions
17. Market Structure Analysis
17.1. Market Structure by Tier
17.2. Product Mapping by Key Manufacturer
18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Profitability and Gross Margin Analysis by Competition
18.4. Competitors Deep Dive
18.4.1. Carl Zeiss AG
18.4.1.1. Overview
18.4.1.2. Product and Application Portfolio
18.4.1.3. Production Footprint
18.4.1.4. Sales Footprint
18.4.1.5. Channel Footprint
18.4.1.6. Strategy
18.4.1.6.1. Marketing Strategy
18.4.1.6.2. Product Strategy
18.4.1.6.3. Channel Strategy
18.4.2. Nidek Co Ltd
18.4.2.1. Overview
18.4.2.2. Product and Application Portfolio
18.4.2.3. Production Footprint
18.4.2.4. Sales Footprint
18.4.2.5. Channel Footprint
18.4.2.6. Strategy
18.4.2.6.1. Marketing Strategy
18.4.2.6.2. Product Strategy
18.4.2.6.3. Channel Strategy
18.4.3. Haag-Streit AG
18.4.3.1. Overview
18.4.3.2. Product and Application Portfolio
18.4.3.3. Production Footprint
18.4.3.4. Sales Footprint
18.4.3.5. Channel Footprint
18.4.3.6. Strategy
18.4.3.6.1. Marketing Strategy
18.4.3.6.2. Product Strategy
18.4.3.6.3. Channel Strategy
18.4.4. Ziemer Ophthalmic Systems
18.4.4.1. Overview
18.4.4.2. Product and Application Portfolio
18.4.4.3. Production Footprint
18.4.4.4. Sales Footprint
18.4.4.5. Channel Footprint
18.4.4.6. Strategy
18.4.4.6.1. Marketing Strategy
18.4.4.6.2. Product Strategy
18.4.4.6.3. Channel Strategy
18.4.5. Optovue, Incorporated
18.4.5.1. Overview
18.4.5.2. Product and Application Portfolio
18.4.5.3. Production Footprint
18.4.5.4. Sales Footprint
18.4.5.5. Channel Footprint
18.4.5.6. Strategy
18.4.5.6.1. Marketing Strategy
18.4.5.6.2. Product Strategy
18.4.5.6.3. Channel Strategy
18.4.6. Topcon Corporation
18.4.6.1. Overview
18.4.6.2. Product and Application Portfolio
18.4.6.3. Production Footprint
18.4.6.4. Sales Footprint
18.4.6.5. Channel Footprint
18.4.6.6. Strategy
18.4.6.6.1. Marketing Strategy
18.4.6.6.2. Product Strategy
18.4.6.6.3. Channel Strategy
18.4.7. TOMEY GmbH
18.4.7.1. Overview
18.4.7.2. Product and Application Portfolio
18.4.7.3. Production Footprint
18.4.7.4. Sales Footprint
18.4.7.5. Channel Footprint
18.4.7.6. Strategy
18.4.7.6.1. Marketing Strategy
18.4.7.6.2. Product Strategy
18.4.7.6.3. Channel Strategy
18.4.8. Movu Inc.
18.4.8.1. Overview
18.4.8.2. Product and Application Portfolio
18.4.8.3. Production Footprint
18.4.8.4. Sales Footprint
18.4.8.5. Channel Footprint
18.4.8.6. Strategy
18.4.8.6.1. Marketing Strategy
18.4.8.6.2. Product Strategy
18.4.8.6.3. Channel Strategy
18.4.9. Newway Technology
18.4.9.1. Overview
18.4.9.2. Product and Application Portfolio
18.4.9.3. Production Footprint
18.4.9.4. Sales Footprint
18.4.9.5. Channel Footprint
18.4.9.6. Strategy
18.4.9.6.1. Marketing Strategy
18.4.9.6.2. Product Strategy
18.4.9.6.3. Channel Strategy
19. Global Next Generation Optical Biometry Devices Market Analysis 2013-2021 and Forecast 2022–2028 by Region
19.1. Introduction / Key Findings
19.2. Historical Market Size (US$ Mn) Analysis by Region
19.2.1. North America
19.2.2. Western Europe
19.2.3. Eastern Europe
19.2.4. Latin America
19.2.5. Asia Pacific Excluding Japan
19.2.6. Japan
19.2.7. Middle East and Africa
19.3. Market Size (US$ Mn) Forecast By Region
19.4. Market Attractiveness Analysis by Region
20. Next Generation Optical Biometry Devices Market Analysis 2013-2021 and Forecast 2022–2028, By Product Type
20.1. Introduction/Key Finding
20.2. Historical Market Value (US$ Mn) and Volume Analysis by Product Type, 2013-2021
20.2.1. Swept-source Optical Coherence Tomography (OCT) based Biometers
20.2.2. Partial coherence interferometry (PCI) based Biometers
20.2.3. Optical Low Coherence Reflectometry (OLCR)based Biometers
20.3. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
20.4. Market Attractiveness Analysis by Product Type
21. Next Generation Optical Biometry Devices Market Analysis 2013-2021 and Forecast 2022–2028, By End User
21.1. Introduction/Key Finding
21.2. Historical Market Size (US$ Mn) Analysis by End User, 2013-2021
21.2.1. Hospitals
21.2.2. Ophthalmology clinics and specialized eye care centers
21.2.3. Ambulatory Surgical centers
21.3. Market Size (US$ Mn) Forecast By End User, 2022–2028
21.4. Market Attractiveness Analysis by End User
22. Next Generation Optical Biometry Devices Market Analysis 2013-2021 and Forecast 2022–2028
22.1. Market Value Share Analysis by All Segment
22.2. Y-o-Y Growth Analysis by All Segment
22.3. Absolute $ Opportunity
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports
Next Generation Optical Biometry Devices Market
